IP Library Granted Patent US 10,932,712
Granted Patent B2
US 10,932,712 · App. 16/023,464 · Granted Mar 2, 2021

Methods and systems for evaluating the integrity of a uterine cavity

Inventors: Akos Toth (Cupertino, CA); Robin Bek (Campbell, CA); Dominique Filloux (Redwood City, CA)
Assignee: Minerva Surgical, Inc.
A61B5/4325A61B5/4836A61B18/042A61B18/1485A61M13/003A61M31/00A61B2017/4216A61B2018/00214A61B2018/00559A61B2018/00577A61B2018/00821A61B2018/147A61B2505/05
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,932,712
App. No.
16/023,464
Granted
Mar 2, 2021
Kind
B2
Abstract

Methods, systems and devices for evaluating the integrity of a uterine cavity. A method comprises introducing transcervically a probe into a patient's uterine cavity, providing a flow of a fluid (e.g., CO 2 ) through the probe into the uterine cavity and monitoring the rate of the flow to characterize the uterine cavity as perforated or non-perforated based on a change in the flow rate.

Claims (12)

1. A system comprising:

a probe having a first lumen, a second lumen and a working end which carries a balloon-like member having a fluid-tight interior chamber;

means for inflating the balloon-like member within the uterine cavity by introducing an inflation media into the fluid-tight interior chamber through the first lumen;

means for introducing a flow of a gas through the second lumen into a uterine cavity exterior of the working end; and

means for measuring a change in volume of inflation media outflow from the inflated balloon in response to the gas flow into the uterine cavity.

2. A system as in claim 1 , wherein the probe is configured to be introduced through a patient's cervix into the patient's uterus.

3. A system as in claim 1 , wherein the gas flow introducing means comprises a pressurized fluid source and a controller configured to deliver the gas at a pre-determined constant pressure.

4. A system as in claim 3 , wherein the pressurized fluid source and the controller are configured to introduce the gas at a pressure in the range from 0.025 psi to 1 psi.

5. A system as in claim 3 , wherein the pressurized fluid source and the controller are configured to deliver gas at a pre-determined initial flow rate.

6. A system as in claim 5 , wherein the initial flow rate is in the range from 0.05 slpm to 0.2 slpm.

7. A system as in claim 5 , wherein the gas volume determined as a function of flow rate and time.

8. A system as in claim 7 , wherein the determining means detects the total gas volume delivered and determines a leakage of gas.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 12, 2026
From: MINERVA SURGICAL, INC.
To: AXORA MEDICAL, INC.
Reel/Frame 075561/0186 →
RELEASE OF SECURITY INTEREST Recorded Feb 5, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: MINERVA SURGICAL, INC.
Reel/Frame 074721/0585 →
SECURITY INTEREST Recorded Jan 30, 2026
From: AXORA MEDICAL, INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 074537/0617 →
SECURITY INTEREST Recorded Oct 8, 2021
From: MINERVA SURGICAL, INC.
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 057758/0137 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2018
From: TOTH, AKOS; BEK, ROBIN; FILLOUX, DOMINIQUE
To: MINERVA SURGICAL, INC.
Reel/Frame 046239/0368 →
Cited By (1)
US 12,274,557